DGS Capital Management’s Aegon AEG Stock Holding History

DGS Capital Management’s Portfolio AEG Stock Details AEG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,007	Closed	-$43.6K	–	220
2022 Q3	$43.6K	Sell	11,007 -7,705	-41%	-$33.5K	0.03%	203
2022 Q2	$80K	Buy	18,712 +4,841	+35%	+$24K	0.06%	184
2022 Q1	$70K	Buy	+13,871	New	+$70.1K	0.04%	192

Other funds holding AEG

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

GWI

Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return

DGS Capital Management's AEG Position: Q4 2022 in Review

DGS Capital Management sold out of Aegon (AEG) in Q4 2022, closing a stake of 11,007 shares — an estimated $43.6K sold.

DGS Capital Management first reported a position in AEG in Q1 2022 and held it in 3 quarters. The position peaked at $80K in Q2 2022. 228 funds tracked by Wall St. Rank hold AEG as of Q4 2022.

DGS Capital Management reported no remaining Aegon position as of Q4 2022 after selling out during the quarter.
DGS Capital Management sold 11,007 Aegon shares in Q4 2022, an estimated $43.6K.
DGS Capital Management first reported a position in Aegon in Q1 2022 and held it in 3 quarters.
DGS Capital Management's Aegon position peaked at $80K in Q2 2022.
228 funds tracked by Wall St. Rank held Aegon as of Q4 2022.

Based on DGS Capital Management's 13F filing for Q4 2022, filed 21 Feb 2023.